HX Diagnostics takes $4.7M for disease diagnostics
HX Diagnostics, maker of quick-acting diagnostic tests for infectious diseases, brought in $4.7 million in equity and securities, according to a filing with the SEC. The company has previously been backed by Kleiner Perkins Caufield & Byers.
Next Story: Financial reporting software maker HyperRoll sells off assets to Oracle
Previous Story: Lunch.com's Twitter Lists make every day #followfriday
About the Author, Camille Ricketts
Camille was the lead writer for GreenBeat until August 2010. To reach VentureBeat's current writers, email tips@venturebeat.com.
